There is available literature to demonstrate TRAF6 targeting in cardiomyopathies such as targeted blockage of CD40 and TRAF6 interaction used in the case of atherosclerosis in mouse models (Lutgens et al., 2010). The gene discussed is TRAF6; the disease is cardiomyopathy.